Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Update on community-acquired pneumonia: impact of antibiotic resistance on clinical outcomes.

Metlay JP. Update on community-acquired pneumonia: impact of antibiotic resistance on clinical outcomes. Current opinion in infectious diseases. 2002 Apr 1; 15(2):163-7.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.    Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions


Abstract:

In contrast to the rapid expansion in the number of published studies reporting the increasing rate of antimicrobial drug resistance among common respiratory pathogens, there remain few controlled studies examining the impact of these trends on clinical outcomes. Those studies that are published are hampered by small sample sizes, biases inherent in observational designs, and the relative infrequency of isolates showing high-level resistance, particularly high-level beta-lactam resistance among clinical isolates of Streptococcus pneumoniae. This update summarizes recent published studies addressing the impact of drug resistance on outcomes for lower respiratory tract infections. The majority of these studies are retrospective cohort studies, focusing on the impact of beta-lactam-resistant pneumococcal infections in patients with community-acquired pneumonia. These studies support the conclusion that current levels of pneumococcal drug resistance do not result in clinical treatment failures for patients with community-acquired pneumonia. However, as patterns of drug resistance evolve, future studies will be needed to address the continued appropriateness of current empirical treatment guidelines for these patients.




Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.